Banque Pictet & Cie’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Banque Pictet & Cie’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-10,000	Closed	-$46K	–	353
2016 Q1	$46K	Sell	10,000 -4,000	-29%	-$16.1K	﹤0.01%	320
2015 Q4	$73K	Sell	14,000 -4,100	-23%	-$23.8K	﹤0.01%	312
2015 Q3	$110K	Hold	18,100	–	–	﹤0.01%	351
2015 Q2	$286K	Hold	18,100	–	–	0.02%	246
2015 Q1	$197K	Hold	18,100	–	–	0.01%	438
2014 Q4	$190K	Hold	18,100	–	–	0.01%	428
2014 Q3	$174K	Hold	18,100	–	–	﹤0.01%	432
2014 Q2	$209K	Buy	18,100 +8,100	+81%	+$73.8K	0.01%	424
2014 Q1	$100K	Hold	10,000	–	–	﹤0.01%	416
2013 Q4	$130K	Buy	+10,000	New	+$138K	﹤0.01%	332

Other funds holding RPTP

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Banque Pictet & Cie's RPTP Position: Q2 2016 in Review

Banque Pictet & Cie sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q2 2016, closing a stake of 10,000 shares — an estimated $46K sold.

Banque Pictet & Cie first reported a position in RPTP in Q4 2013 and held it in 10 quarters. The position peaked at $286K in Q2 2015. 93 funds tracked by Wall St. Rank hold RPTP as of Q2 2016.

Banque Pictet & Cie reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q2 2016 after selling out during the quarter.
Banque Pictet & Cie sold 10,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q2 2016, an estimated $46K.
Banque Pictet & Cie first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2013 and held it in 10 quarters.
Banque Pictet & Cie's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $286K in Q2 2015.
93 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q2 2016.

Based on Banque Pictet & Cie's 13F filing for Q2 2016, filed 10 Aug 2016.